38 Anemia of Chronic Disease Flashcards

1
Q

Term more reflective of the pathophysiology of ACD

A

Anemia of inflammation (AI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A condition that presents similarly to anemia of chronic disease but develops within days of the onset of illness

A

Anemia of critical illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

An anemia similar to AI is seen in some older patients in the absence of an identifiable chronic disease

A

Unexplained anemia of elderlies or anemia of aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Key characteristic of AI

A

Inadequate erythrocyte production in the setting of low serum iron and low iron-binding capacity (ie, low transferrin) despite preserved or even increased macrophage iron stores in the marrow

The erythrocytes are usually normocytic and normochromic but can be mildly hypochromic and microcytic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patients with_____________ are often at least partially spared, likely because cysts cause local ischemia with resultant increased local EPO production

A

Polycystic kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology of anemia of chronic kidney disease (anemia of CKD)

A

Relative EPO deficiency

Others:
Systemic inflammation, true iron deficiency, and decreased clearance of hepcidin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The second or third most common form of anemia after iron deficiency anemia (IDA) and possibly thalassemia

A

Anemia of inflammation (AI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The term that describes rare disorders where hemophagocytosis by activated macrophages is the predominant cause of anemia

A

“Consumptive anemia of inflammation”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cytokines that exert a suppressive effect on erythroid colony formation

A

Tumor necrosis factor-α (TNF-α), IL-1, and Interferon-γ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

One of the defining features of AI that develops within hours of the onset of inflammation

A

Hypoferremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Induces the iron-regulatory hormone, hepcidin

A

IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Amount of iron that daily enters the plasma iron/transferrin pool comes from macrophage recycling of senescent erythrocytes and from hepatocyte iron stores

A

20–25 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amount of iron derived from dietary iron

A

1–2 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amount of iron bound to transferrin

A

2–4 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hepcidin acts by binding to cell membrane–associated __________ molecules that are the only conduits for iron export, and inducing occlusion, internalization, and degradation.

A

Ferroportin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

As an intermediate step during the synthesis of heme, iron becomes incorporated into protoporphyrin_____.

A

Protoporphyrin IX

17
Q

Mineral that is an alternative protoporphyrin ligand

A

Zinc

18
Q

In AI, zinc protoporphyrin is (increased or decreased).

A

Increased

19
Q

In AI, the number of sideroblasts is (increased or decreased)

A

Decreased

20
Q

TRUE OR FALSE

In AI, iron deficiency contribute to the anemia, in that coadministration of parenteral iron can resolve the resistance of AI to EPO

A

TRUE

In AI, iron deficiency contribute to the anemia, in that coadministration of parenteral iron can resolve the resistance of AI to EPO

21
Q

In AI, transferrin is (increased or decreased).

A

Decreased

22
Q

In AI, ferritin is (increased or decreased).

A

Increased

23
Q

Depending on the severity of inflammation, coexisting iron deficiency should be suspected if ferretin level is less than _______ in the presense of significant inflammation.

A

Less than 100 mcg/L

24
Q

Soluble transferrin receptor (sTfR) levels (increased or decreased) during infection or inflammation.

A

Decreased

25
Q

Another promising marker that may differentiate AI from systemic iron deficiency is serum ________, because very low serum levels in hypoferremia are diagnostic of systemic iron deficiency.

A

Hepcidin

26
Q

TRUE OR FALSE

Marrow aspiration or biopsy is required for the diagnosis of AI.

A

FALSE

Marrow aspiration or biopsy is rarely required for the diagnosis of AI.

27
Q

The most important information obtained from marrow examination is the

A

Content and distribution of iron

28
Q

Iron in a marrow preparation can be found as

A

Storage iron in the cytoplasm of macrophages
Functional iron in nucleated red cells

29
Q

Approximately one-third of nucleated red cells contain 1–4 blue inclusion bodies by light microscopy, and such cells are called

A

Sideroblasts

30
Q

In AI, sideroblasts are (increased or decreased) , but macrophage iron is (increased or decreased)

A

Decreased or absent

Increased

31
Q

Marrow staining that could be considered the gold standard for differential diagnosis of AI and iron deficiency

A

Prussian blue stain

32
Q

TRUE OR FALSE

When AI and chronic blood loss coexist, serum ferritin usually indicates the predominant disorder, although the level can increase as a result of inflammation itself.

A

TRUE

When AI and chronic blood loss coexist, serum ferritin usually indicates the predominant disorder, although the level can increase as a result of inflammation itself.

33
Q

EPO is recommended in treating patients with Hb less than ______ g/dL

A

10 g/dL

34
Q

The FDA-approved starting dose of epoetin

A

150 U/kg three times per week or 40,000 U weekly

35
Q

The FDA-approved starting dose of darbepoetin

A

2.25 mcg/kg weekly or 500 mcg every 3 weeks

36
Q

Continuing epoetin or darbepoetin treatment beyond ______weeks in the absence of response (achieving less than 1–2 g/dL rise in Hb) does not appear to be beneficial and EPO therapy should be discontinued.

A

6–8 weeks

37
Q

For adult patients, these guidelines recommend that a newly anemic patient with CKD should have laboratory studies to rule out B12 and folate deficiency, and a therapeutic trial of intravenous iron if their transferrin saturation level is _______and ferritin is less than ______ ng/mL.

A

30% or lower

less than 500 ng/mL